Literature DB >> 8835872

Pathogenesis of dilated cardiomyopathy and heart failure: insights from cell morphology and biology.

S Hein1, J Schaper.   

Abstract

The cause of dilated cardiomyopathy is not yet clear but the recent discovery of a chromosomal aberration as well as the presence of autoantibodies indicate a multicausal origin. Knowledge of pathogenetic mechanisms continues to evolve and includes decreased sarcoplasmic reticulum Ca2+ uptake, reduced beta-receptor density and decreased contractility, the presence of enlarged myocytes showing numerous degenerative alterations, and fibrosis. Defects in titin, a large sarcomeric protein, may be responsible for disturbances of sarcomerogenesis in dilated cardiomyopathy. New animal models are promising but significant progress will also be made using cell culture systems like adult cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835872     DOI: 10.1097/00001573-199605000-00010

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Authors:  M A Sussman; S Welch; N Gude; P R Khoury; S R Daniels; D Kirkpatrick; R A Walsh; R L Price; H W Lim; J D Molkentin
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease.

Authors:  P Skyllouriotis; M Skyllouriotis-Lazarou; S Natter; R Steiner; S Spitzauer; S Kapiotis; P Valent; A M Hirschl; S E Guber; G Laufer; G Wollenek; E Wolner; M Wimmer; R Valenta
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.

Authors:  V Subbarayan; M Mark; N Messadeq; P Rustin; P Chambon; P Kastner
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  AgNORs in the myocardium in ischaemic heart disease complicated by heart failure: a postmortem study.

Authors:  N N Mamaev; A Y Gudkova; K K Amineva
Journal:  Mol Pathol       Date:  1998-04

Review 6.  Titin as a modular spring: emerging mechanisms for elasticity control by titin in cardiac physiology and pathophysiology.

Authors:  Henk Granzier; Dietmar Labeit; Yiming Wu; Siegfried Labeit
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 3.352

Review 7.  Animal Models and "Omics" Technologies for Identification of Novel Biomarkers and Drug Targets to Prevent Heart Failure.

Authors:  Yunlong Hou; Juan M Adrian-Segarra; Manfred Richter; Natalia Kubin; Jaeyoung Shin; Isabella Werner; Thomas Walther; Markus Schönburg; Jochen Pöling; Henning Warnecke; Thomas Braun; Sawa Kostin; Thomas Kubin
Journal:  Biomed Res Int       Date:  2015-07-07       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.